Cargando…
Stress-dependent dilated cardiomyopathy in mice with cardiomyocyte-restricted inactivation of cyclic GMP-dependent protein kinase I
AIMS: Cardiac hypertrophy is a common and often lethal complication of arterial hypertension. Elevation of myocyte cyclic GMP levels by local actions of endogenous atrial natriuretic peptide (ANP) and C-type natriuretic peptide (CNP) or by pharmacological inhibition of phosphodiesterase-5 was shown...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3631523/ https://www.ncbi.nlm.nih.gov/pubmed/22199120 http://dx.doi.org/10.1093/eurheartj/ehr445 |
_version_ | 1782266792204304384 |
---|---|
author | Frantz, Stefan Klaiber, Michael Baba, Hideo A. Oberwinkler, Heike Völker, Katharina Gaβner, Birgit Bayer, Barbara Abeβer, Marco Schuh, Kai Feil, Robert Hofmann, Franz Kuhn, Michaela |
author_facet | Frantz, Stefan Klaiber, Michael Baba, Hideo A. Oberwinkler, Heike Völker, Katharina Gaβner, Birgit Bayer, Barbara Abeβer, Marco Schuh, Kai Feil, Robert Hofmann, Franz Kuhn, Michaela |
author_sort | Frantz, Stefan |
collection | PubMed |
description | AIMS: Cardiac hypertrophy is a common and often lethal complication of arterial hypertension. Elevation of myocyte cyclic GMP levels by local actions of endogenous atrial natriuretic peptide (ANP) and C-type natriuretic peptide (CNP) or by pharmacological inhibition of phosphodiesterase-5 was shown to counter-regulate pathological hypertrophy. It was suggested that cGMP-dependent protein kinase I (cGKI) mediates this protective effect, although the role in vivo is under debate. Here, we investigated whether cGKI modulates myocyte growth and/or function in the intact organism. METHODS AND RESULTS: To circumvent the systemic phenotype associated with germline ablation of cGKI, we inactivated the murine cGKI gene selectively in cardiomyocytes by Cre/loxP-mediated recombination. Mice with cardiomyocyte-restricted cGKI deletion exhibited unaltered cardiac morphology and function under resting conditions. Also, cardiac hypertrophic and contractile responses to β-adrenoreceptor stimulation by isoprenaline (at 40 mg/kg/day during 1 week) were unaltered. However, angiotensin II (Ang II, at 1000 ng/kg/min for 2 weeks) or transverse aortic constriction (for 3 weeks) provoked dilated cardiomyopathy with marked deterioration of cardiac function. This was accompanied by diminished expression of the [Ca(2+)](i)-regulating proteins SERCA2a and phospholamban (PLB) and a reduction in PLB phosphorylation at Ser(16), the specific target site for cGKI, resulting in altered myocyte Ca(2+)(i) homeostasis. In isolated adult myocytes, CNP, but not ANP, stimulated PLB phosphorylation, Ca(2+)(i)-handling, and contractility via cGKI. CONCLUSION: These results indicate that the loss of cGKI in cardiac myocytes compromises the hypertrophic program to pathological stimulation, rendering the heart more susceptible to dysfunction. In particular, cGKI mediates stimulatory effects of CNP on myocyte Ca(2+)(i) handling and contractility. |
format | Online Article Text |
id | pubmed-3631523 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-36315232013-04-22 Stress-dependent dilated cardiomyopathy in mice with cardiomyocyte-restricted inactivation of cyclic GMP-dependent protein kinase I Frantz, Stefan Klaiber, Michael Baba, Hideo A. Oberwinkler, Heike Völker, Katharina Gaβner, Birgit Bayer, Barbara Abeβer, Marco Schuh, Kai Feil, Robert Hofmann, Franz Kuhn, Michaela Eur Heart J Basic Science AIMS: Cardiac hypertrophy is a common and often lethal complication of arterial hypertension. Elevation of myocyte cyclic GMP levels by local actions of endogenous atrial natriuretic peptide (ANP) and C-type natriuretic peptide (CNP) or by pharmacological inhibition of phosphodiesterase-5 was shown to counter-regulate pathological hypertrophy. It was suggested that cGMP-dependent protein kinase I (cGKI) mediates this protective effect, although the role in vivo is under debate. Here, we investigated whether cGKI modulates myocyte growth and/or function in the intact organism. METHODS AND RESULTS: To circumvent the systemic phenotype associated with germline ablation of cGKI, we inactivated the murine cGKI gene selectively in cardiomyocytes by Cre/loxP-mediated recombination. Mice with cardiomyocyte-restricted cGKI deletion exhibited unaltered cardiac morphology and function under resting conditions. Also, cardiac hypertrophic and contractile responses to β-adrenoreceptor stimulation by isoprenaline (at 40 mg/kg/day during 1 week) were unaltered. However, angiotensin II (Ang II, at 1000 ng/kg/min for 2 weeks) or transverse aortic constriction (for 3 weeks) provoked dilated cardiomyopathy with marked deterioration of cardiac function. This was accompanied by diminished expression of the [Ca(2+)](i)-regulating proteins SERCA2a and phospholamban (PLB) and a reduction in PLB phosphorylation at Ser(16), the specific target site for cGKI, resulting in altered myocyte Ca(2+)(i) homeostasis. In isolated adult myocytes, CNP, but not ANP, stimulated PLB phosphorylation, Ca(2+)(i)-handling, and contractility via cGKI. CONCLUSION: These results indicate that the loss of cGKI in cardiac myocytes compromises the hypertrophic program to pathological stimulation, rendering the heart more susceptible to dysfunction. In particular, cGKI mediates stimulatory effects of CNP on myocyte Ca(2+)(i) handling and contractility. Oxford University Press 2013-04-21 2011-12-23 /pmc/articles/PMC3631523/ /pubmed/22199120 http://dx.doi.org/10.1093/eurheartj/ehr445 Text en Published on behalf of the European Society of Cardiology. All rights reserved. © The Author [2011]. http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Basic Science Frantz, Stefan Klaiber, Michael Baba, Hideo A. Oberwinkler, Heike Völker, Katharina Gaβner, Birgit Bayer, Barbara Abeβer, Marco Schuh, Kai Feil, Robert Hofmann, Franz Kuhn, Michaela Stress-dependent dilated cardiomyopathy in mice with cardiomyocyte-restricted inactivation of cyclic GMP-dependent protein kinase I |
title | Stress-dependent dilated cardiomyopathy in mice with cardiomyocyte-restricted inactivation of cyclic GMP-dependent protein kinase I |
title_full | Stress-dependent dilated cardiomyopathy in mice with cardiomyocyte-restricted inactivation of cyclic GMP-dependent protein kinase I |
title_fullStr | Stress-dependent dilated cardiomyopathy in mice with cardiomyocyte-restricted inactivation of cyclic GMP-dependent protein kinase I |
title_full_unstemmed | Stress-dependent dilated cardiomyopathy in mice with cardiomyocyte-restricted inactivation of cyclic GMP-dependent protein kinase I |
title_short | Stress-dependent dilated cardiomyopathy in mice with cardiomyocyte-restricted inactivation of cyclic GMP-dependent protein kinase I |
title_sort | stress-dependent dilated cardiomyopathy in mice with cardiomyocyte-restricted inactivation of cyclic gmp-dependent protein kinase i |
topic | Basic Science |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3631523/ https://www.ncbi.nlm.nih.gov/pubmed/22199120 http://dx.doi.org/10.1093/eurheartj/ehr445 |
work_keys_str_mv | AT frantzstefan stressdependentdilatedcardiomyopathyinmicewithcardiomyocyterestrictedinactivationofcyclicgmpdependentproteinkinasei AT klaibermichael stressdependentdilatedcardiomyopathyinmicewithcardiomyocyterestrictedinactivationofcyclicgmpdependentproteinkinasei AT babahideoa stressdependentdilatedcardiomyopathyinmicewithcardiomyocyterestrictedinactivationofcyclicgmpdependentproteinkinasei AT oberwinklerheike stressdependentdilatedcardiomyopathyinmicewithcardiomyocyterestrictedinactivationofcyclicgmpdependentproteinkinasei AT volkerkatharina stressdependentdilatedcardiomyopathyinmicewithcardiomyocyterestrictedinactivationofcyclicgmpdependentproteinkinasei AT gabnerbirgit stressdependentdilatedcardiomyopathyinmicewithcardiomyocyterestrictedinactivationofcyclicgmpdependentproteinkinasei AT bayerbarbara stressdependentdilatedcardiomyopathyinmicewithcardiomyocyterestrictedinactivationofcyclicgmpdependentproteinkinasei AT abebermarco stressdependentdilatedcardiomyopathyinmicewithcardiomyocyterestrictedinactivationofcyclicgmpdependentproteinkinasei AT schuhkai stressdependentdilatedcardiomyopathyinmicewithcardiomyocyterestrictedinactivationofcyclicgmpdependentproteinkinasei AT feilrobert stressdependentdilatedcardiomyopathyinmicewithcardiomyocyterestrictedinactivationofcyclicgmpdependentproteinkinasei AT hofmannfranz stressdependentdilatedcardiomyopathyinmicewithcardiomyocyterestrictedinactivationofcyclicgmpdependentproteinkinasei AT kuhnmichaela stressdependentdilatedcardiomyopathyinmicewithcardiomyocyterestrictedinactivationofcyclicgmpdependentproteinkinasei |